OVOLs	OVO-like proteins
EMT	Epithelial–mesenchymal transition
MET	Mesenchymal–epithelial transition
R-SMADs	Receptor-regulated SMADs
Co-SMAD	Common mediator SMAD
TβRI	TGF-β type I receptor
CRC	Colorectal cancer
HDAC1	Histone deacetylase 1
TRX	Thioredoxin
GCLC	Glutamate cysteine ligase
TRPV1	Transient receptor potential vanilloid 1
HCC	Hepatocellular carcinoma
ESCC	Esophageal squamous cell carcinoma
NPC	Nasopharyngeal carcinoma
RA	Retinoic acid
OXCT1	3-Oxoacid CoA-transferase 1
FAO	Fatty acid oxidation
CSCC	Cutaneous squamous cell carcinoma
ATC	Anaplastic thyroid carcinoma
NSCLC	Non-small cell lung cancer
TCA	Tricarboxylic acid
TNBC	Triple-negative breast cancer
APOE	Apolipoprotein E
TMB	Tumor mutational burden
TME	Tumor microenvironment
ccRCC	Clear cell renal cell carcinoma
AD	Atopic dermatitis
FLG	Filaggrin
LOR	Loricrin
TSLP	Thymic stromal lymphopoietin
ILC2s	Group 2 innate lymphoid cells
EoE	Eosinophilic esophagitis
LUAD	Lung adenocarcinoma
OS	Overall survival
LUSC	Lung squamous cell carcinoma
RFS	Relapse-free survival
PFS	Progression-free survival
CXPA	Carcinoma ex pleomorphic adenoma
MSS	Melanoma-specific survival
DSS	Disease-specific survival
PFI	Progression-free interval